Module D: Pharmaceutical Treatments & Interventions

CE Credits: 1.5


While IBD consists of chronic and often difficult diseases, it can be managed with a combination of proper pharmaceutical treatments and, just as important, a commitment to a treatment plan. This module begins by looking at the most common pharmaceutical treatments, such as 5-ASA compounds and corticosteroids, which can help with inflammation due to IBD; and biologic agents, which act as anti-tumor necrosis factor agents. The module then details the pros and cons of various pharmaceuticals, in terms of benefits and possible side effects, such as skin problems and increased vulnerability to infection. Finally, the module looks at adjunct treatments, such as anti-spasmodics or anti-diarrheal medications, though some are used off-label for UC and CD.

Learning objectives: After completing this module the case manager will be able to:
» Review the spectrum of pharmaceutical interventions associated with UC and CD care
» Discuss issues associated with managing complex medication regimens
» Describe types and characteristics of pharmaceutical agents for UC and CD patients
» Identify adjunct medications used in UC and CD management

Advance your professional practice:: Case managers share with patients the goal of helping them get into remission and stay there. When we know the differences and strengths among various treatment regimens, we can tailor the best treatment plan for each patient.By understanding how deeply IBD can affect a patient’s daily life and mindset—and how difficult it can be to manage without the right information and support—case managers can be sensitive to patients’ needs and challenges, and help them achieve better management and more positive outcomes.


Improve organizational performance: The goal of IBD patients is to achieve (and stay in) remission for as long as possible. When the entire team understands the range of pharmaceutical treatments, we can help patients choose the best strategy to achieve the best outcomes and remain out of the hospital.